BRCA2 and lung carcinoma: This includes the rs11571833 nonsense polymorphism in the terminal exonof BRCA2, which is a reported lung cancer susceptibility variant, butwas not associated with PrCa in this study (OR 1.03, 95% CI0.89–1.19, P=0.74) (Wanget al, 2014).